Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases. Its flagship product, DefenCath, is an FDA-approved antimicrobial catheter lock solution designed to reduce bloodstream infections in dialysis patients. The company targets healthcare providers and hospitals in the U.S., leveraging reimbursement mechanisms and proprietary patents to address significant unmet medical needs in infection prevention and vascular access management.
This description was generated via AI from an annual report. Updated about 1 year ago.